We’re pleased to welcome Celia J.F. Lin, M.D., as Chief Medical Officer. A rheumatologist and clinical development leader, Dr. Lin will guide NVG-2089 through Phase 2 studies and advance our BESTech™ platform for autoimmune disease. https://t.co/mrierWtpcS

We’re honored to be named one of @FierceBiotech’s 2025 Fierce 15! Nuvig is advancing NVG-2089, a recombinant Fc-fragment designed to offer a potent, patient-friendly alternative to IVIG in #autoimmunedisease, now in Phase 2 clinical trials. https://t.co/BwjsNJntqh #Fierce15

Today we welcome David J. Woodhouse as CEO and share that James Mackay will now serve as Independent BOD Chair. We look forward to their leadership as we advance NVG-2089 in Phase 2 #clinicaltrials in #autoimmunedisease and expand our BESTech™ platform. https://t.co/SArsYBwp3z

How can IVIG’s anti-inflammatory effects be delivered with less patient burden? We spoke with @neurology_live about how NVG-2089, in #clinicaltrials for CIDP, may offer similar benefit at lower doses and shorter infusion times. https://t.co/rbQubnltaB https://t.co/L5R4Wb7prO

We’re pleased to share that we’ve dosed the first patient in our Phase 2 CIDP trial evaluating NVG-2089, a recombinant Fc fusion protein designed to replicate key immunomodulatory functions of IVIg with improved consistency and convenience. https://t.co/uorfS5dcZZ

We’re proud to be featured in @Forbes as a biotech reshaping #autoimmunedisease treatment. Our lead candidate, NVG-2089, has the potential to be a potent, patient-friendly alternative to IVIG and is now entering Phase 2 clinical trials. https://t.co/mQd6JKE6OU #biotechstowatch

Honored to be named one of the U.S. #biotech companies to watch by @DDWJournal. Nuvig is advancing novel, non-immunosuppressive therapies to restore immune balance and improve outcomes for patients with #autoimmunedisease. Read more: https://t.co/qQeCtHN2eo #biotechstowatch

We’re looking for a (Sr.) Clinical Research Associate! Join us and help advance innovative therapies for #autoimmunediseases. If you have clinical trial experience & want to make an impact, apply today: https://t.co/HWAXrclfBa #biotech #clinicalresearch #hiring

We’re excited to announce a $161M Series B #financing to advance our innovative, non-immunosuppressive therapies for #autoimmunediseases and the progression of our lead program into Phase 2 #clinicaltrials Thank you to our investors for your support! https://t.co/OvVKis2lTU

We are #hiring a Staff Accountant! If you’re passionate about precision, numbers, and supporting breakthrough scientific innovation, this is your opportunity to grow with us! See the #openposition here: https://t.co/HWAXrclfBa #biotech #BayArea #careers #wearehiring

We are #hiring a Director of Regulatory Affairs! If you're an expert in navigating the complex world of biotech regulations and passionate about advancing innovative therapies, see the #openposition here: https://t.co/HWAXrclfBa #biotech #BayArea #careers #wearehiring

Are you passionate about supporting a great team that is working to advance new medicines for those affected by autoimmune disease? We are #hiring a Manager, Clinical Supply Chain! Learn more: https://t.co/HWAXrclfBa #biotech #BayArea #careers #wearehiring #openposition

Are you passionate about supporting a great team that is working to advance new medicines for those affected by autoimmune disease? We are #hiring an #ExecutiveAssistant! Learn more: https://t.co/HWAXrclfBa #biotech #BayArea #careers #wearehiring #openposition

Are you passionate about advancing novel therapeutics for those affected by #autoimmune disease? We're #hiring a #ClinicalTrial Manager, Director/Sr. Director #ClinicalOperations, & Sr. Medical Director Learn more: https://t.co/HWAXrckHLC #biotech #BayArea #clinicaldevelopment

Nuvig Initiates Clinical Development of Next-Generation Immune Modulator NVG-2089 https://t.co/bYCxsSdUnD

We welcome Dr. Alan Glicklich as our new CMO! With 25+ years of experience advancing novel drug candidates and building teams to ensure quality and safety, his leadership will advance our innovative drug candidates for chronic #autoimmunediseases. https://t.co/y0smTX9y4T

We are thrilled to welcome Bella Oguno as VP of Development Operations and Karen Grimm as Senior Director of Analytical Development to the Nuvig Therapeutics team. Their leadership and experience will be key to helping us develop innovative therapies for #autoimmunediseases.

Are you passionate about advancing novel therapeutics for those affected by #autoimmune disease? We are #hiring a Medical Director, VP & Director of #ClinicalOperations, and VP of #RegulatoryAffairs. #JoinUs: https://t.co/HWAXrclfBa #biotech #hematologist #clinicaldevelopment

We are excited to announce the appointment of Julie Anne Smith as CEO. Her experience in leading private and public #biotech companies will be essential as we advance our lead program into IND-enabling studies. https://t.co/Uw4hgVbzXF #inflammation #autoimmunediseases

We are excited to welcome Joseph Leung as Director of CMC Biologics Manufacturing! Joe has > 13 years of experience in process development and manufacturing of antibodies, bispecifics, and antibody-drug conjugates. #biotech #bayarea #autoimmunediseases #chronicinflammation